No Data
No Data
Cartesian Stock Climbs 8% on FDA Regenerative Therapy Designation
Express News | Cartesian Therapeutics Shares up 8.3% on Fda's 'rmat' Tag for Autoimmune Disorder Treatment
Express News | Cartesian- on Track to Post Topline Data From Phase 2B Randomized, Placebo-Controlled Trial of Descartes-08 in Patients With Mg in Mid-2024
Express News | Cartesian Therapeutics Secures FDA Regenerative Medicine Advanced Therapy Designation For Descartes-08 For Treatment Of Myasthenia Gravis
Express News | Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (Rmat) Designation for Descartes-08 for the Treatment of Myasthenia Gravis
Cartesian Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
GAITHERSBURG, Md., May 13, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ:RNAC) (the "Company), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today
No Data
T-24Century : looking good hehe
T-24Century : they add around 12m shares and the float is now at 280m from 55m before de added shares.
TrytosaveabitOP T-24Century: I think they have that wrong?
T-24Century : how can you calculate the math?
the price should be maybe 38 -40?
TrytosaveabitOP T-24Century: That depends! Some calculate the market cap using shares in lockup and unregistered shares? Me I just use the price it’s trading at times the number of shares that are available for trading! That’s the difference between Float Market cap and Full Market Capitalization! Hope this help?
View more comments...